COVID-19 Vaccines for Children with Developmental Disabilities: Survey of New York State Parents' Willingness and Concerns

Bonuck, Karen; Iadarola, Suzannah; Gao, Qi; Siegel, Joanne F.

doi:10.1097/dbp.0000000000001113

Cited by 4 publications

(6 citation statements)

References 22 publications

(39 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among those parents who were uncertain or did not intend to vaccinate their child, the most common reason was the parental concerns about the safety of the vaccination. This result is in accordance with those that have been observed in other recent studies worldwide examining immunization confidence among different groups of individuals ( 14 , 22 , 41–44 ). Therefore, it is of great importance targeting the interventions to address these concerns raised by the parents by a participatory approach and it is also necessary to stress the dangers of this vaccine-preventable disease.…”

Section: Discussionsupporting

confidence: 93%

“…There is overwhelming evidence supporting that parents are the decision-makers regarding the vaccination for their children and the attitudes are key determinants in the vaccine acceptance and uptake. Cross-sectional studies have investigated the willingness of parents of children ages 6 months to 4 years in many places (10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20) but limited information was available regarding children with frail conditions (21)(22)(23). Such data are paramount to COVID-19 vaccine uptake rates.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Willingness and hesitancy of parents to vaccinate against COVID-19 their children ages 6 months to 4 years with frail conditions in Italy

Giudice

Polla

Postiglione

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

BackgroundIn Italy, on December 2022, COVID-19 vaccination was recommended for children aged 6 months-4 years with frail conditions and for those healthy. The purposes of the survey were to understand parental willingness and hesitancy toward COVID-19 vaccination of children with frail conditions in Italy and related influencing factors.MethodsA cross-sectional survey was performed among 445 parents with a child aged 6 months-4 years with frail conditions who attended a teaching hospital and a public hospital randomly selected in the city of Naples, Italy.ResultsAlmost one third (29.9%) were willing to vaccinate their frail children against COVID-19, whereas 21.3% were uncertain, and 48.8% did not intend to vaccinate. Parents with a higher level of perception that the vaccine is useful and safe and those who had received information by pediatrician were more likely to be willing to vaccinate their child. The mean Parent Attitudes About Childhood Vaccines (PACV-5) score was 3.4, with 13.5% of parents high-hesitant for the COVID-19 vaccination for their child. Parents with a higher COVID-19 vaccine-related safety concerns, those who have delayed at least one shot of a recommended vaccine for their child, and those who did not have received at least three doses of the vaccine against SARS-CoV-2 were more likely to be high-hesitant.ConclusionThe survey findings have important implications for designing interventions to increase willingness and to reduce hesitancy for COVID-19 vaccine among parents of frail children aged 6 months-4 years in Italy.

show abstract

Section: Discussionsupporting

confidence: 93%

Section: Introductionmentioning

confidence: 99%

Willingness and hesitancy of parents to vaccinate against COVID-19 their children ages 6 months to 4 years with frail conditions in Italy

Giudice

Polla

Postiglione

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…Significant overlap was observed with respect to concerns about vaccine safety as well as topics related to children and vaccines (eg, safety in children, effects on child development, and safety in pregnancy). These patterns align with our previous community research on vaccine concerns as well as those documented in national surveys [ 3 , 20 , 37 ]. The connection between Ana topics and community concerns was in itself a positive outcome and an intentional aim of the project.…”

Section: Discussionsupporting

confidence: 89%

COVID-19 Vaccine Equity and Access: Case Study for Health Care Chatbots

Pérez-Ramos¹,

Leon-Thomas²,

Smith³

et al. 2023

JMIR Form Res

Self Cite

View full text Add to dashboard Cite

Background Disparities in COVID-19 information and vaccine access have emerged during the pandemic. Individuals from historically excluded communities (eg, Black and Latin American) experience disproportionately negative health outcomes related to COVID-19. Community gaps in COVID-19 education, social, and health care services (including vaccines) should be prioritized as a critical effort to end the pandemic. Misinformation created by the politicization of COVID-19 and related public health measures has magnified the pandemic’s challenges, including access to health care, vaccination and testing efforts, as well as personal protective equipment. Information and Communication Technology (ICT) has been demonstrated to reduce the gaps of marginalization in education and access among communities. Chatbots are an increasingly present example of ICTs, particularly in health care and in relation to the COVID-19 pandemic. Objective This project aimed to (1) follow an inclusive and theoretically driven design process to develop and test a COVID-19 information ICT bilingual (English and Spanish) chatbot tool named “Ana” and (2) characterize and evaluate user experiences of these innovative technologies. Methods Ana was developed following a multitheoretical framework, and the project team was comprised of public health experts, behavioral scientists, community members, and medical team. A total of 7 iterations of ß chatbots were tested, and a total of 22 ß testers participated in this process. Content was curated primarily to provide users with factual answers to common questions about COVID-19. To ensure relevance of the content, topics were driven by community concerns and questions, as ascertained through research. Ana’s repository of educational content was based on national and international organizations as well as interdisciplinary experts. In the context of this development and pilot project, we identified an evaluation framework to explore reach, engagement, and satisfaction. Results A total of 626 community members used Ana from August 2021 to March 2022. Among those participants, 346 used the English version, with an average of 43 users per month; and 280 participants used the Spanish version, with an average of 40 users monthly. Across all users, 63.87% (n=221) of English users and 22.14% (n=62) of Spanish users returned to use Ana at least once; 18.49% (n=64) among the English version users and 18.57% (n=52) among the Spanish version users reported their ranking. Positive ranking comprised the “smiley” and “loved” emojis, and negative ranking comprised the “neutral,” “sad,” and “mad” emojis. When comparing negative and positive experiences, the latter was higher across Ana’s platforms (English: n=41, 64.06%; Spanish: n=41, 77.35%) versus the former (English: n=23, 35.93%; Spanish: n=12, 22.64%). Conclusions This pilot project demonstrated the feasibility and capacity of an innovative ICT to share COVID-19 information within diverse communities. Creating a chatbot like Ana with bilingual content contributed to an equitable approach to address the lack of accessible COVID-19–related information.

show abstract

“…A survey for SARS-CoV-2 vaccine perceptions in New York State's intellectual and developmental disabilities community indicated concerns toward side effects and the swiftness of vaccine development [28] . An online survey of parents of children with developmental disability (DD) in New York revealed the parents were highly willing for their children to receive SARS-CoV-2 vaccines [29] .…”

Section: Introductionmentioning

confidence: 99%

Medical outcomes of children with neurodevelopmental disorders after SARS-CoV-2 vaccination: A six-month follow-up study

Wang

Tsai

Chou

et al. 2023

Vaccine

View full text Add to dashboard Cite

COVID-19 Vaccines for Children with Developmental Disabilities: Survey of New York State Parents' Willingness and Concerns

Cited by 4 publications

References 22 publications

Willingness and hesitancy of parents to vaccinate against COVID-19 their children ages 6 months to 4 years with frail conditions in Italy

Willingness and hesitancy of parents to vaccinate against COVID-19 their children ages 6 months to 4 years with frail conditions in Italy

COVID-19 Vaccine Equity and Access: Case Study for Health Care Chatbots

Medical outcomes of children with neurodevelopmental disorders after SARS-CoV-2 vaccination: A six-month follow-up study

Contact Info

Product

Resources

About